Med Ed Report briefs

Share this article:
Unbound Medicine was named the official electronic publisher of the web- and mobile-based versions of Johns Hopkins' Antibiotic (ABX), Diabetes and HIV POC-IT Guides. The clinical decision support tool provides information to healthcare professionals at the point of care.

Doug Young, PhD, was named VP, Touchpoint clinical solutions at Publicis Touchpoint Solutions. The firm specializes in clinical health educator programs, MSL teams and integrated adherence and retention programs. Young served most recently as VP, global medical affairs, BMS.

Elsevier said the Cleveland Clinic physicians will develop ongoing content updates and reviews for Elsevier's First Consult clinical reference tool, according to a new strategic collaboration announced by the medical publisher. The Clinic currently provides point-of-care CME credit to users of Elsevier's First Consult and MD Consult tools.

Vindico Medical Education received accreditation with commendation as a provider of CME by the ACCME. ACCME accreditation with commendation, also known as Level 3 accreditation, ranks Vindico among the top 8% of providers of CME in the US.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?